ISOLDE Workshop and Users meeting 2018

Session

Technical Session 2

7 Dec 2018, 09:00

503/1-001 - Council Chamber (CERN)

Conveners

Technical Session 2

• Yacine Kadi (CERN)

51. Operations of the REX/HIE-ISOLDE linac during the 2018 Physics Campaign

Jose Alberto Rodriguez (CERN)

07/12/2018, 09:00

Invited

The 2018 ISOLDE high energy Physics campaign started last July, immediately after Phase 2B of the HIE-ISOLDE project was completed. Since then, multiple stable and Radioactive Ion Beams (RIBs) have been delivered to the three different experimental stations (Miniball, ISS and the Scattering chamber) and fourteen experiments have been conducted. The main issues and the operational highlights...

50. REX and HIE ISOLDE post-accelerator shutdown work

Mr Erwin Siesling (CERN)

07/12/2018, 09:30

Invited

This presentation will give you an overview of the foreseen maintenance and modifications during the Long-Shutdown 2 period related to the ISOLDE post-accelerator REX and HIE ISOLDE as well as the High Energy Beam Transferlines.

41. REX/HIE-ISOLDE Machine Development

Niels Killian Noal Bidault (CERN, INFN & Sapienza University of Rome)

07/12/2018, 09:50

Invited

Several aspects of optimisation or development towards a more complete understanding of the REX/HIE-ISOLDE linear accelerator will be presented.

We will first demonstrate the possibility to map a spectrum of contamination from residual gas ions, on a wide mass-to-charge ratio range, helping on the anticipation of the ion beam purity. Additionally, an effort for the optimisation of the ion...

16. Charge breeding investigations for a future 11C treatment facility

Fredrik John Carl Wenander (CERN)

07/12/2018, 10:10

Submitted

Within work-package 2 of the MEDICIS-Promed ITN we study the possibilities of using a radioactive therapy beam in hadron therapy. In particular, 11C (β+ emitter, t1/2=20.3 min) is investigated as it has excellent properties for both on-line and off-line PET imaging, which can be used for dose verification. While ions are produced abundantly in conventional hadron therapy with stable carbon, it...